Open AccessHypertriglyceridemia and Its Pharmacologic Treatment Among US Adults
Author(s) -
Earl S. Ford,
Chaoyang Li,
Guixiang Zhao,
William S. Pearson,
Ali H. Mokdad
Publication year - 2009
Publication title -
archives of internal medicine
Language(s) - English
Resource type - Journals
eISSN - 1538-3679
pISSN - 0003-9926
DOI - 10.1001/archinternmed.2008.599
Subject(s) - hypertriglyceridemia , gemfibrozil , fenofibrate , medicine , triglyceride , medical prescription , obesity , niacin , gastroenterology , endocrinology , cholesterol , pharmacology
Increasing evidence supports triglyceride (TG) concentration as a risk factor for cardiovascular disease. The prevalence of hypertriglyceridemia during a period of rising prevalence of obesity and its pharmacological treatment among US adults are poorly understood.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom